Back to news

Evaxion to announce strategy and business update and third quarter 2026 financial results on November 19, 2026

Globe Newswire•18/11/2026•08:30 ET
1

Key Highlights

  • ➤Evaxion to report third-quarter 2026 financial results November 19 before Nasdaq CM opening
  • ➤Management will provide a strategy and business update during November 19 conference call
  • ➤Evaxion will host an 8.30am ET/14.30 CET conference call and webcast

COPENHAGEN, Denmark, November 18, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, will provide a strategy and business update and report its third quarter 2026 financial results on Thursday November 19, 2026, before opening of the Nasdaq CM.

Evaxion’s executive management will host a conference call and webcast at 8.30am ET/14.30 CET the same day, presenting the strategy and business update and financial results as well as taking questions.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in